PHASE 2 STUDY OF PEVONEDISTAT + AZACITIDINE VERSUS AZACITIDINE IN PATIENTS WITH HIGHER-RISK MYELODYSPLASTIC SYNDROMES/CHRONIC MYELOMONOCYTIC LEUKEMIA OR LOW-BLAST ACUTE MYELOGENOUS LEUKEMIA (NCT02610777)

• L. Adès,
• J. Watts,
• A. Radinoff,
• M.A. Sangerman,
• M. Cerrano,
• P.F. Lopez,
• J. Zeidner,
• M.D. Campelo,
• C. Graux,
• J. Liesveld,
• D. Selleslag,
• N. Tzvetkov,
• R.J. Fram,
• D. Zhao,
• J. Bell,
• S. Friedlander,
• D.V. Faller,
• M.A. Sekeres

Affiliations

L. Adès

Hôpital Saint-Louis, Paris, France

J. Watts

Sylvester Comprehensive Cancer Center, University of Miami, Miami, United States

A. Radinoff

University Hospital Sveti Ivan Rislki, Sofia, Bulgaria

M.A. Sangerman

Institut Català d’Oncologia-Institut d’Investigació Biomèdica de Bellvitge (IDIBELL), Hospitalet, Barcelona, Spain

M. Cerrano

Department of Molecular Biotechnology and Health Sciences, Division of Hematology, University of Turin, Turin, Italy

P.F. Lopez

Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón (IiSGM), Madrid, Spain

J. Zeidner

University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, United States

M.D. Campelo

Department of Hematology, University Hospital of Salamanca (HUS/IBSAL), CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain

C. Graux

Université Catholique de Louvain, Centre Hospitalier Universitaire, Namur, Yvoir, Belgium

J. Liesveld

The James P Wilmot Cancer Institute, University of Rochester, Rochester, United States

D. Selleslag

AZ Sint Jan Brugge-Oostende, Brugge, Belgium

N. Tzvetkov

MHAT Dr. Georgi Stranski, Clinic of Haematology, Pleven, Bulgaria

R.J. Fram

Millennium Pharmaceuticals, Inc., Cambridge, United States, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.

D. Zhao

Millennium Pharmaceuticals, Inc., Cambridge, United States, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.

J. Bell

Millennium Pharmaceuticals, Inc., Cambridge, United States, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.

S. Friedlander

Millennium Pharmaceuticals, Inc., Cambridge, United States, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.

D.V. Faller

Millennium Pharmaceuticals, Inc., Cambridge, United States, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.

M.A. Sekeres

Cleveland Clinic, Cleveland, United States